50580-507-02 : NDC 2026 Code

50580-507-02 : Acetaminophen, Guaifenesin, And Phenylephrine Hydrochloride ( Tylenol Sinus Severe )

Additionally :

You can get information about “50580-507-02” NDC code in 50580-507-02 in HTML format

HTML | 50580-507-02 in TXT (Plain Text) format

TXT | 50580-507-02 in PDF (Portable Document Format)

PDF | 50580-507-02 in XML format

XML formats.

NDC Code : 50580-507-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "50580-507-02",
    "PackageDescription": "3 CARTON in 1 PACKAGE (50580-507-02)  / 2 BLISTER PACK in 1 CARTON / 12 TABLET, COATED in 1 BLISTER PACK",
    "NDC11Code": "50580-0507-02",
    "ProductNDC": "50580-507",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Tylenol Sinus Severe",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Acetaminophen, Guaifenesin, And Phenylephrine Hydrochloride",
    "DosageFormName": "TABLET, COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20150515",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "M012",
    "LabelerName": "Kenvue Brands LLC",
    "SubstanceName": "ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE",
    "StrengthNumber": "325; 200; 5",
    "StrengthUnit": "mg/1; mg/1; mg/1",
    "Pharm_Classes": "Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-11-05",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20200706",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}